Dr. Jeremy Richmon, MD

Dr. Richmon practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Richmon's NPI, 1871658369, was assigned on December 26, 2006. Dr. Richmon graduated from University of Rochester School of Medicine and Dentistry in 2001. Dr. Richmon holds Massachusetts license 267646.

Dr. Richmon's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Richmon's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Richmon is also affiliated with Brigham and Women's Hospital. The medical group on file is Atrius Health. Dmand AI also links Dr. Richmon to 3 more hospitals, 1 community health center, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Richmon practices, 7 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Richmon's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Richmon is licensed in Massachusetts.

CMS data shows 890 Medicare services from Dr. Richmon across 9 procedure codes in 2024, for 443 Medicare patients. Medicare paid $81,473 for them.

CMS counts 443 Medicare patients who saw Dr. Richmon in 2024. The largest group is 65 to 74, with 228 patients. 72% of them have high cholesterol, and 67% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Richmon's median patient age at 69, with 36% women.

In 2024, Dr. Richmon wrote 96 Medicare Part D claims for 41 patients. 100% of them were for generic drugs. CMS names the drug for 62 of them, across 3 drugs with 11 or more claims each, at $871 in total drug cost. In 2021, CMS named 14 claims across 1 drug.

Dr. Richmon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Richmon as offering telehealth. CMS counts 15 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Richmon, more than 46% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 159 papers to Dr. Richmon, published from 2010 to 2025. 2021 was the busiest year, with 13. The most frequent topics are Head and Neck Neoplasms, Plastic Surgery Procedures and Carcinoma, Squamous Cell. Dr. Richmon has published most often in Head Neck. Dr. Richmon's most frequent co-authors are Daniel G. Deschler, MD, Allen Lee Feng, MD and Carole Fakhry, MD.

Dmand AI links Dr. Richmon to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Papillomavirus Infections and Oropharyngeal Neoplasms.

CMS Open Payments shows 25 general payments to Dr. Richmon from 3 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 55% of the total. Intuitive Surgical, Inc. paid the most, $7,188.

Dr. Richmon graduated from University of Rochester School of Medicine and Dentistry in 2001.